H2-receptor antagonists in the treatment of complicated gastroesophageal reflux disease: "for whom the bell tolls"

Editorial

M B Fennerty et al. Gastroenterology. 1994 Nov.

. 1994 Nov;107(5):1545-8.

doi: 10.1016/0016-5085(94)90562-2.

No abstract available

Comment in

The reasons for ineffectiveness of H2-receptor antagonists in gastroesophageal reflux disease.
Savarino V, Mela GS, Celle G. Savarino V, et al. Gastroenterology. 1995 Jun;108(6):1958-9. doi: 10.1016/0016-5085(95)90179-5. Gastroenterology. 1995. PMID: 7768408 No abstract available.

Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.
Hallerbäck B, Unge P, Carling L, Edwin B, Glise H, Havu N, Lyrenäs E, Lundberg K. Hallerbäck B, et al. Gastroenterology. 1994 Nov;107(5):1305-11. doi: 10.1016/0016-5085(94)90531-2. Gastroenterology. 1994. PMID: 7926494 Clinical Trial.
A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group.
Smith PM, Kerr GD, Cockel R, Ross BA, Bate CM, Brown P, Dronfield MW, Green JR, Hislop WS, Theodossi A, et al. Smith PM, et al. Gastroenterology. 1994 Nov;107(5):1312-8. doi: 10.1016/0016-5085(94)90532-0. Gastroenterology. 1994. PMID: 7926495 Clinical Trial.